Aceto Corporation (NASDAQ:ACET) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders.
On December 1, 2016, Aceto Corporation (the Company) held its
Annual Meeting of Shareholders (the Meeting). The matters voted
on at the Meeting were: the election of directors, approval of an
amendment to the Companys Certificate of Incorporation to reduce
the shareholder vote required to approve certain transactions,
approval of an advisory vote on executive compensation and the
ratification of the appointment of the Companys independent
registered public accounting firm. The final voting results were
as follows:
1. |
The election of nominees Albert L. Eilender, Salvatore Guccione, Hans C. Noetzli, William N. Britton, Natasha Giordano, Alan G. Levin, Dr. Daniel B. Yarosh and William C. Kennally, III as directors of the Company to hold office until the next annual meeting of stockholders and until their successors shall be elected. |
|
The votes were cast with respect to this matter as follows: |
FOR |
WITHHELD |
BROKER NON-VOTES |
|||
Albert L. Eilender | 23,615,810 | 265,317 | 3,409,589 | ||
Salvatore Guccione | 23,643,396 | 237,731 | 3,409,589 | ||
Hans C. Noetzli | 23,581,932 | 299,195 | 3,409,589 | ||
William N. Britton | 23,697,354 | 183,773 | 3,409,589 | ||
Natasha Giordano | 23,768,095 | 113,032 | 3,409,589 | ||
Alan G. Levin | 23,715,476 | 165,651 | 3,409,589 | ||
Dr. Daniel B. Yarosh | 23,730,675 | 150,452 | 3,409,589 | ||
William C. Kennally, III | 23,677,410 | 203,717 | 3,409,589 | ||
Each nominee was elected a director of the Company. |
2. |
Approval of an amendment to the Companys Certificate of Incorporation to reduce the shareholder vote required to approve certain transactions. |
|
The votes were cast with respect to this matter as follows: |
FOR | AGAINST | ABSTAIN | BROKER NON-VOTES |
23,248,719 | 584,351 | 48,057 | 3,409,589 |
2 |
The amendment to the Companys Certificate of Incorporation to reduce the shareholder vote required to approve certain transactions was approved. |
||
3. |
The proposal to approve, on an advisory basis, executive compensation was approved based upon the following votes: |
FOR | AGAINST | ABSTAIN | BROKER NON-VOTES |
22,992,496 | 771,820 | 116,811 | 3,409,589 |
4. |
The proposal to ratify the appointment of BDO USA, LLP as the Companys independent registered public accounting firm for the Companys fiscal year ending June 30, 2017 was approved based upon the following votes: |
FOR | AGAINST | ABSTAIN | ||
26,793,650 | 458,357 | 38,709 |
3 |
About Aceto Corporation (NASDAQ:ACET)
Aceto Corporation (Aceto) is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The Company’s business is organized along product lines into three segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. As of June 30, 2016, it distributed over 1,100 chemical compounds used primarily as finished products or raw materials in the agricultural, coatings and industrial chemical industries. The Human Health segment includes finished dosage form generic drugs and nutraceutical products. As of June 30, 2016, the Pharmaceutical Ingredients segment had two product groups: Active Pharmaceutical Ingredients and Pharmaceutical Intermediates. The Performance Chemicals segment includes specialty chemicals and agricultural protection products. Aceto Corporation (NASDAQ:ACET) Recent Trading Information
Aceto Corporation (NASDAQ:ACET) closed its last trading session up +0.20 at 20.40 with 173,996 shares trading hands.